Lupin shines on getting approval from USFDA for Sildenafil for oral suspension
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2022/03/62fb316441f75ddda95bd0db08285cb2.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Lupin is currently trading at Rs. 773.65, up by 26.55 points or 3.55% from its previous closing of Rs. 747.10 on the BSE.
The scrip opened at Rs. 747.10 and has touched a high and low of Rs. 777.35 and Rs. 743.25 respectively. So far 127797 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1267.50 on 02-Jun-2021 and a 52 week low of Rs. 678.65 on 07-Mar-2022.
Last one week high and low of the scrip stood at Rs. 777.35 and Rs. 743.25 respectively. The current market cap of the company is Rs. 35122.23 crore.
The promoters holding in the company stood at 46.81%, while Institutions and Non-Institutions held 40.39% and 12.79% respectively.
Lupin has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Sildenafil for Oral Suspension, 10 mg/mL to market a generic equivalent of Revatio for Oral Suspension, 10 mg/mL, of Viatris Specialty LLC. The product will be manufactured at Lupin's facility in Goa, India. Sildenafil for Oral Suspension, 10 mg/mL (RLD Revatio) had estimated annual sales of $66 million in the U.S. (IQVIA MAT December 2021).
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.
![](https://portfolio.investmentguruindia.com/uploads/news/Clean Science and Technology.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Somany logo.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Axis Securities Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/startup.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Srinivas Narayanan.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Mongolia.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/nitingadkari37.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/jul03v68_wcHr0zT.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/IT Sector03.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Bharti Airtel Ltd.jpg)
Tag News
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/09/a2c1327cde647ed452f791dec3d81da0.jpg)
Lupin inches up on collaborating with Mark Cuban Cost Plus Drug Company and COPD Foundation
More News
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/07/16cdd7c858f6c8991a7cb5531719a339.jpg)
REC shines on inking MoU with PMI Electro Mobility
![Surya Roshni surges on targeting double-digit growth from lighting & consumer durable business in FY24](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/07/e5848b80f84f4903fa05aeded307b650.jpg)
![Key News - Aditya Birla Sun Life AMC Ltd, Godrej Industries Ltd, Crisil, Adani Group, Tata Consultancy Services Ltd, Dish TV Ltd By ARETE Securities](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2021/09/8a3ebad94a0c44df72a083c48e502b98.jpg)
![Coal India surges on gearing up to meet its part of committed coal supplies to power sector](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2022/06/95bb75489570877d507cea96ae401add.jpg)